Fujifilm’s Ultrasound System Cleared for Use in COVID-19 Patients

Fujifilm subsidiary Sonosite has received 510(k) clearance from the FDA for its point-of-care ultrasound system (POCUS) for performing lung and cardiac imaging in COVID-19 patients.

Coinciding with the clearance, the company is releasing a user guide to help healthcare professionals correctly interpret the ultrasound images to recognize the most typical COVID-19 findings relating to lung and cardiac conditions.

With the widespread use of ultrasound by many different types of clinicians during the pandemic, “education is more important than ever,” the company said.